Maxim Group Begins Coverage on Kairos Pharma (NYSEAMERICAN:KAPA)
Maxim Group assumed coverage on shares of Kairos Pharma (NYSEAMERICAN:KAPA – Get Free Report) in a research report issued to clients and investors on Thursday,Benzinga reports. The firm set a “buy” rating and a $4.00 price target on the stock. Maxim Group’s target price indicates a potential upside of 334.12% from the stock’s current price. […]
Maxim Group assumed coverage on shares of Kairos Pharma (NYSEAMERICAN:KAPA – Get Free Report) in a research report issued to clients and investors on Thursday,Benzinga reports. The firm set a “buy” rating and a $4.00 price target on the stock. Maxim Group’s target price indicates a potential upside of 334.12% from the stock’s current price. […]
